FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approves Apotex Corp.'s supplemental application for Desmopressin Acetate, enabling the generic version to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Diabetes Insipidus
• Hemophilia
• Nocturnal Enuresis
• Von Willebrand Disease

Drugs mentioned

• Desmopressin Acetate (Desmopressin acetate)

Snippet

SUPPL AP for DESMOPRESSIN ACETATE (DESMOPRESSIN ACETATE)